FXH

First Trust Health Care AlphaDEX Fund

Down$74.46
$-0.02
(-0.03%)
As of 3:59:59 PM EDT | 10/16/19  |  Market Open

FXH Trading Data

Open

$74.5

Low Price

$74.35

High Price

$74.86

Previous Last Price

$74.48

Bid Size

$0 X 0

Ask Size

$0 X 0

FXH Portfolio Data

AUM

$1,011,678,000

Shares

13,800

PE Ratio

23.8

Price / Book Ratio

3.77

Expense Ratio

0.63

Net Asset Value

$73.31

Volume

Volume

60,884

Avg. Volume (YDT)

222,489

Dollar Volume

$3,968,050

Weekly Avg. Volume

80,003

Monthly Avg. Volume

89,246

Quarterly Avg. Volume

86,622

FXH Fund Description

The First Trust Health Care AlphaDEX Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant Health Care Index. The gross expense ratio for this fund is 0.61%. Expenses are capped contractually at 0.70% per year, at least until November 30, 2017.

FXH Chart

FXH Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust Health Care AlphaDEX Fund

Inception Date

2007-05-08

Asset Class

Equity

Asset Class Size

Biotech

FXH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

FXH Holdings

Top 10 Holdings

First Trust Health Care AlphaDEX Fund (FXH)
0%
Edwards Lifesciences Corporation (EW)
0%
Molina Healthcare Inc. (MOH)
0%
Zoetis Inc. (ZTS)
0%
Alexion Pharmaceuticals Inc. (ALXN)
0%
Chemed Corporation (CHE)
0%
Bio-Rad Laboratories Inc. (Class A) (BIO)
0%
Horizon Therapeutics Plc (HZNP)
0%
ResMed Inc. (RMD)
0%
Biogen Inc. (BIIB)
0%

Total FXH Holdings

Total Holdings: 80

First Trust Health Care AlphaDEX Fund (FXH)
0%
Edwards Lifesciences Corporation (EW)
0%
Molina Healthcare Inc. (MOH)
0%
Zoetis Inc. (ZTS)
0%
Alexion Pharmaceuticals Inc. (ALXN)
0%
Chemed Corporation (CHE)
0%
Bio-Rad Laboratories Inc. (Class A) (BIO)
0%
Horizon Therapeutics Plc (HZNP)
0%
ResMed Inc. (RMD)
0%
Biogen Inc. (BIIB)
0%
Seattle Genetics Inc. (SGEN)
0%
Insulet Corporation (PODD)
0%
Exelixis Inc. (EXEL)
0%
MEDNAX Inc. (MD)
0%
Mylan N.V. (MYL)
0%
Jazz Pharmaceuticals Plc (JAZZ)
0%
Regeneron Pharmaceuticals Inc. (REGN)
0%
DexCom Inc. (DXCM)
0%
Centene Corporation (CNC)
0%
Humana Inc. (HUM)
0%
Bristol-Myers Squibb Company (BMY)
0%
Cigna Corporation (CI)
0%
Gilead Sciences Inc. (GILD)
0%
Pfizer Inc. (PFE)
0%
West Pharmaceutical Services Inc. (WST)
0%
Veeva Systems Inc. (Class A) (VEEV)
0%
Cardinal Health Inc. (CAH)
0%
Laboratory Corporation of America Holdings (LH)
0%
Stryker Corporation (SYK)
0%
Universal Health Services Inc. (Class B) (UHS)
0%
McKesson Corporation (MCK)
0%
Teleflex Incorporated (TFX)
0%
Amgen Inc. (AMGN)
0%
WellCare Health Plans Inc. (WCG)
0%
IDEXX Laboratories Inc. (IDXX)
0%
Johnson & Johnson (JNJ)
0%
Anthem Inc. (ANTM)
0%
HCA Healthcare Inc. (HCA)
0%
AmerisourceBergen Corporation (ABC)
0%
Bruker Corporation (BRKR)
0%
DaVita Inc. (DVA)
0%
Agilent Technologies Inc. (A)
0%
Danaher Corporation (DHR)
0%
Hologic Inc. (HOLX)
0%
Quest Diagnostics Incorporated (DGX)
0%
Steris Plc (STE)
0%
Thermo Fisher Scientific Inc. (TMO)
0%
Premier Inc. (Class A) (PINC)
0%
Baxter International Inc. (BAX)
0%
Encompass Health Corporation (EHC)
0%
Charles River Laboratories International Inc. (CRL)
0%
Medtronic Plc (MDT)
0%
Merck & Co. Inc. (MRK)
0%
Becton Dickinson and Company (BDX)
0%
Cerner Corporation (CERN)
0%
Masimo Corporation (MASI)
0%
Neurocrine Biosciences Inc. (NBIX)
0%
The Cooper Companies Inc. (COO)
0%
IQVIA Holdings Inc. (IQV)
0%
Abbott Laboratories (ABT)
0%
Hill-Rom Holdings Inc. (HRC)
0%
Perrigo Company Plc (PRGO)
0%
QIAGEN N.V. (QGEN)
0%
Ionis Pharmaceuticals Inc. (IONS)
0%
UnitedHealth Group Incorporated (UNH)
0%
Bio-Techne Corporation (TECH)
0%
Exact Sciences Corporation (EXAS)
0%
Incyte Corporation (INCY)
0%
AbbVie Inc. (ABBV)
0%
Catalent Inc. (CTLT)
0%
Elanco Animal Health Incorporated (ELAN)
0%
Eli Lilly and Company (LLY)
0%
ICU Medical Inc. (ICUI)
0%
PRA Health Sciences Inc. (PRAH)
0%
Boston Scientific Corporation (BSX)
0%
Intuitive Surgical Inc. (ISRG)
0%
PerkinElmer Inc. (PKI)
0%
Cantel Medical Corp. (CMD)
0%
Varian Medical Systems Inc. (VAR)
0%
Morgan Stanley Institutional Liquidity Fund - Treasury Portfolio (MISXX)
0%

FXH Technicals

Alpha

-2.46

Beta

1.05

Leverage

Long

Standard Deviation

3.38

FXH Dividends

Dividend Date

2013-06-21

Latest Dividend

0.0055

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FXH Performance

YTD Return

8.19%

1 Year Return

-7.84%

3 Year Return

27.27%

5 Year Return

29.64%

10 Year Return

294.07%

FXH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.